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INTRODUCTION
The inflammatory nature of atherosclerosis and certain links between infection and atherothrombosis have been described by many researchers (Ross, 1973; Ross et al., 1976; Ross, 1986; 1993a; 1993b) .
Chronic infection could be one of the possible causative factors involved as it causes dysfunction and inflammation of endothelium (Libby et al., 1997) . Infection agents and viruses damage and transform the vascular wall, thus directly causing endothelium and smooth muscle cell dysfunction. Indirect influence on both atherosclerosis and atherothrombosis can occur by affecting leukocytes (including macrophages and lymphocytes, commonly found in atheromata) in the following ways: decrease of fibrinolytic activity, stimulation of procoagulant and cytotoxin production, and atherogenic changes in lipid metabolism. Infectious agents are essential for the immune system activation; it has been shown that flu vaccinated individuals less frequently develop acute vascular events, compared to unvaccinated people (Nichol et al., 2003; Smeeth et al., 2004) .
Cytomegalovirus (CMV), known as Human Herpesvirus (HHV5), belongs to the beta Herpes virus subfamily (Mocarski et al., 2001) and is found in all geographic regions and socioeconomic groups (Ryan et al., 2004) . CMV infects between 50% and 80% of the population, and its seroprevalence is age-dependent. CMV may affect any organ. As a latent infection it persists in the organism over long periods, and intermittently can be transmitted to the environment. The virus is associated with the salivary glands. Development of CMV is dependent on many factors: route of infection, genetic features of the host, as well as the immune system status. CMV can be found in all bodily fluids -urine, saliva, tears, sperm, and breast milk (Ho, 1990) . Postnatally, infection mainly affects the respiratory and digestive systems. In blood CMV mainly replicates in macrophages (leukocytes and monocytes), or persists in the lymphoid tissues. A CMV infected macrophage induces MCR-1 (monocyte chemotactic protein) expression. Therefore, CMV can be considered as a MCR-1 expression "mediator", the mechanism leading to endothelial damage (Stern et al., 2008) . Similar to Chlamydia pneumoniae, chronic CMV infection is also associated with vascular smooth muscle cell proliferation (Epstein et al., 1999 ) and increase of carotid atherosclerosis and intima media thickness (Nieto et al., 1996) . Studies focused on CMV identification in atherosclerotic plaques have showed ambiguous results, moreover, virus antibody titres have not always correlated with clinical findings (Chiu et al., 1997; Saetta et al., 2000) . CMV diagnostics are based on serologic and molecular methods.
The aim of our study was to compare the plasma Cytomegalovirus IgG antibody level in a stroke patient and control groups and to determine association of homocysteine with ischemic stroke and with stroke subtype.
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MATERIALS AND METHODS
This study was prospective and all patients (n = 102) included in this study were hospitalised in Pauls Stradiòð Clinical University Hospital in the Clinic of Neurology with the diagnosis of acute ischemic stroke (61 males, 41 females; mean age 65.8 ± 10.9 years; age range 42 to 89 years). The control group included 48 people (26 males, 22 females; mean age: 64.3 ± 11.8 years; age range 42 to 82 years). Patients were divided into three groups according to TOAST criteria: patients with atherotrombotic stroke subtype (n = 36), cardioembolic stroke subtype (n = 47) and with undetermined aetiology subtype (n = 19). General characteristics of the 102 cases in subgroups are presented in Tables 1 and 2 . The average age of patients in subgroups significantly differed (F = 4.631; P < 0.05), which can be explained by different pathogenesis and aetiology mechanisms in the stroke subgroups.
The severity of neurological status of patients was clinically evaluated using the Rankin scale. Special inquiry forms were completed for each of patients with the following information: stroke localisation (ACM, ACA or VB territory), and stroke risk factors (hypertension, diabetes, cigarettesmoking, blood lipids and others).
Quantitative/qualitative determination of IgG antibodies to Cytomegalovirus in plasma and sera (ADALTIS EIAgen Cytomegalovirus IgG Kit) in plasma was conducted by ELISA. The test had in vitro diagnostic use only. Microplates are coated with native Cytomegalovirus antigen, highly purified by sucrose gradient centrifugation and inactivated. The solid phase was first treated with the diluted sample and immunoglobulin G (IgG) to Cytomegalovirus were captured, if present, by the antigens. After washing out all of the components of the sample, in the 2 nd incubation, bound anti Cytomegalovirus Ig G were detected by the addition of polyclonal specific and hIgG antibodies, labelled with peroxidase (HRP). The enzyme captured on the solid phase, acting on the substrate/chromogen mixture, generates an optical signal that is proportional to the amount of anti CMV IgG antibodies present in the sample. A Calibration Curve, calibrated as the 1 st WHO international standard was used for quantitative determination of the IgG antibody in the patient. Samples with a concentration lower than 0.5 IU/ml are considered negative for anti Cytomegalovirus IgG antibody. Samples with a concentration higher than 0.5 IU/ml were considered positive for anti-CMV IgG antibody.
Persons with blood samples whose anti-CMV IgG antibody concentration was expected to be higher than 8 IU/ml in this study were classified as patients who had massive contact with virus.
SPSS 16 software was used for statistical data processing.
To test hypotheses in line with the set tasks and type of data the parametric and non-parametric statistical methods were used.
RESULTS
CMV IgG seropositivity was not associated with a particular case group. The prevalence of Ig G higher than 0.5 IU/ml did not differ between patient and control groups (χ 2 = 0.02; P > 0.05) ( Table 3) . Subgroup analyses show similar negative results (Table 4 ).
The mean CMV IgG antibody level was not significantly higher in the patient group (t = 1.274; P > 0.05) ( Table 5 ). There was no significant difference between mean level of CMV antibody in different stroke subtypes (F = 3.27; P < 0.05) ( Table 6 ).
The patient and control groups were divided into two subgroups -with IgG to CMV level from 0.5 IU/ml to 8 IgG, immunoglobulin G; * P > 0.05; CMV, Cytomegalovirus IU/ml and above 8 IU/ml (Table 7) . The prevalence of seropositivity to IgG (>8 IU/ml) antibodies was significantly higher in cardioembolic stroke cases (75%) than in controls (52%) (x = 5.11; P < 0.05). These results suggest that associations between high concentration of anti CMV IgG and atherosclerosis is mostly found in cardiovascular patients.
We found a correlation between CMV IgG antibody level and leucocitosis (r = 0.282; P < 0.05), coronary heart disease (r = 0.239; P < 0.05), and thickness of intima-media complex (r = 0,221; P < 0.05), which might suggest CMV seropositivity as a stimulator of chronic inflammation and an independent predictor of atherosclerosis.
DISCUSSION
Our study does not provide an unambiguous answer on the role of chronic infection in stroke etiology. Several problems should be solved in order to confirm the infection theory. Chronic infection is widespread in the population, and therefore, can not be considered as a specific risk factor. In our study, CMV IgG seropositivity was detected in 93% of the patient group and in 94% of the control group cases. Cytomegalovirus chronic infection is an associate with proliferation of vascular smooth-muscle cells (Epstein et al., 2004) and increase thickness of intima-media complex (Nieto et al., 1996) . In our study, we also found a correlation between CMV IgG antibody level and thickness of intima-media complex (r = 0.221; P < 0.05). We can not also exclude the importance of cytomegalovirus chronic infection combination with other risk factors, such as coronary heart disease (Amarenco et al., 1994) and white blood cell count (Grau et al., 2001) . This study shows an association between CMV IgG antibody level and leucocitosis (r = 0.282; P < 0.05) and coronary heart disease (r = 0.239; P < 0.05).
It still remains unclear whether chronic infection induces the onset of atherosclerosis, or merely contributes to the progression of the latter. In the search for clinical evidence for the chronic infection theory, more verified associations between microorganisms and atherosclerosis have been mostly found in cardiovascular patients, where diversity of risk factors have been excluded. This can be difficult to achieve in stroke patients due to stroke heterogeneity.
Another important problem to solve is the methodology of detection: the optimal method for detecting of the infectious agents has not been accepted yet. The role played by molecular methods in a routine diagnostic virus laboratory is still small compared to conventional methods. One of the newer molecular techniques is the polymerase chain reaction (PCR). PCR has many problems, mainly contamination, since only a minute amount of contamination is needed to give a false positive result. In addition, because PCR is so sensitive compared to other techniques, a positive PCR result is often very difficult to interpret as it does not necessarily indicate the presence of disease. This problem is particularly large in the case of latent viruses such as CMV, since latent CMV genomes may be amplified from the blood of healthy individuals. Serology forms the mainstay of viral diagnosis, as it shows primary humoral immune response to antigen. The ELISA method is relatively cheap, sufficiently sensitive and more often is used as a routine method in clinical practice.
The definition of chronic infection in perspective probably can be recommended as a routine analysis, especially for stroke patients with dyslipidemia, coronary heart disease, 
